May 7th 2021
press releases
May 3rd 2021
analyst reports
April 29th 2021
press releases
April 19th 2021
press releases
April 16th 2021
press releases
April 14th 2021
investor updates
Upcoming Events
Whats next.
passion.
It takes a great deal of passion to pursue the fight against cancer and autoimmune diseases. We put our heart and soul into winning it.
know-how.
Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.
research.
Accurate research and development is the strongest foundation for developing effective treatments.
What is LAG-3?
Lymphocyte-activation gene 3, or LAG-3 (LAG3), is a gene that provides the genetic information to make a cell surface molecule with biologic effects on T cell function.
LAG-3 is being used for many immunotherapy treatments including Eftilagimod Alpha from Immutep.
